273 related articles for article (PubMed ID: 18426405)
1. Transforming growth factor-beta in cutaneous melanoma.
Javelaud D; Alexaki VI; Mauviel A
Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
[TBL] [Abstract][Full Text] [Related]
2. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and malignant melanoma: molecular mechanisms.
Hussein MR
J Cutan Pathol; 2005 Jul; 32(6):389-95. PubMed ID: 15953371
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta and cancer: a love-hate relationship?
Reiss M
Oncol Res; 1997; 9(9):447-57. PubMed ID: 9495450
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta/Smad signaling in the injured liver.
Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor beta in cancer.
Pasche B
J Cell Physiol; 2001 Feb; 186(2):153-68. PubMed ID: 11169452
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling in breast cancer.
Buck MB; Knabbe C
Ann N Y Acad Sci; 2006 Nov; 1089():119-26. PubMed ID: 17261761
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Sno expression in malignant melanoma.
Poser I; Rothhammer T; Dooley S; Weiskirchen R; Bosserhoff AK
Int J Oncol; 2005 May; 26(5):1411-7. PubMed ID: 15809735
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling in tumor suppression and cancer progression.
Derynck R; Akhurst RJ; Balmain A
Nat Genet; 2001 Oct; 29(2):117-29. PubMed ID: 11586292
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
Verrecchia F; Mauviel A; Farge D
Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling: a tale of two responses.
Rahimi RA; Leof EB
J Cell Biochem; 2007 Oct; 102(3):593-608. PubMed ID: 17729308
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins in melanoma: angel or devil?
Hsu MY; Rovinsky S; Penmatcha S; Herlyn M; Muirhead D
Cancer Metastasis Rev; 2005 Jun; 24(2):251-63. PubMed ID: 15986135
[TBL] [Abstract][Full Text] [Related]
15. A mathematical model of the stoichiometric control of Smad complex formation in TGF-beta signal transduction pathway.
Nakabayashi J; Sasaki A
J Theor Biol; 2009 Jul; 259(2):389-403. PubMed ID: 19358856
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta and colorectal carcinogenesis.
Roman C; Saha D; Beauchamp R
Microsc Res Tech; 2001 Feb; 52(4):450-7. PubMed ID: 11170304
[TBL] [Abstract][Full Text] [Related]
17. Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling.
Söderberg SS; Karlsson G; Karlsson S
Ann N Y Acad Sci; 2009 Sep; 1176():55-69. PubMed ID: 19796233
[TBL] [Abstract][Full Text] [Related]
18. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
[TBL] [Abstract][Full Text] [Related]
19. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
20. The role of transforming growth factor beta signaling in messenger RNA stability.
Dibrov A; Kashour T; Amara FM
Growth Factors; 2006 Mar; 24(1):1-11. PubMed ID: 16393690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
